Clinuvel Pharmaceuticals Limited (CLVLY)
OTCMKTS · Delayed Price · Currency is USD
7.60
-0.55 (-6.75%)
Feb 12, 2026, 11:53 AM EST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of $383.05 million as of February 12, 2026. Its market cap has increased by 0.84% in one year.
Market Cap
383.05M
Enterprise Value
223.91M
Revenue
62.29M
Ranking
n/a
PE Ratio
16.15
Stock Price
$7.60
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 2.79M to 383.05M, an increase of 13,634.75%. That is a compound annual growth rate of 21.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 388.77M | -6.82% |
| Dec 31, 2025 | 417.22M | 11.93% |
| Dec 31, 2024 | 372.77M | -31.82% |
| Dec 29, 2023 | 546.72M | -24.87% |
| Dec 30, 2022 | 727.74M | -25.56% |
| Dec 31, 2021 | 977.57M | 14.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |